IRIS
BARBANTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.000
EU - Europa 7.966
NA - Nord America 3.787
SA - Sud America 348
AF - Africa 21
OC - Oceania 8
Totale 21.130
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 7.778
IE - Irlanda 5.955
US - Stati Uniti d'America 3.769
SG - Singapore 1.016
GB - Regno Unito 831
CH - Svizzera 405
BR - Brasile 319
FI - Finlandia 307
IT - Italia 162
DE - Germania 148
CN - Cina 84
EE - Estonia 40
CZ - Repubblica Ceca 32
NL - Olanda 28
KR - Corea 25
FR - Francia 14
CA - Canada 13
TR - Turchia 12
IR - Iran 11
EC - Ecuador 10
AR - Argentina 9
UZ - Uzbekistan 9
AT - Austria 8
EG - Egitto 8
IN - India 8
PK - Pakistan 8
RU - Federazione Russa 8
AU - Australia 7
TW - Taiwan 7
BD - Bangladesh 5
MA - Marocco 5
UA - Ucraina 5
IQ - Iraq 4
JP - Giappone 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BG - Bulgaria 3
ES - Italia 3
ID - Indonesia 3
IL - Israele 3
LV - Lettonia 3
MX - Messico 3
NP - Nepal 3
PH - Filippine 3
PL - Polonia 3
UG - Uganda 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
CY - Cipro 2
JO - Giordania 2
LT - Lituania 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 21.130
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.777
Dublin 5.918
London 816
Boardman 800
Ashburn 792
Santa Clara 408
Zurich 405
Helsinki 306
Singapore 204
Washington 197
Los Angeles 60
Assago 42
Munich 38
Seoul 25
São Paulo 24
Chicago 23
Brno 21
Seattle 21
Milan 19
Shanghai 14
Amsterdam 13
Brasília 12
Falkenstein 12
Frankfurt am Main 12
Catania 11
Olomouc 11
Clifton 9
Düsseldorf 9
Piscataway 9
Belo Horizonte 8
Rome 8
Tappahannock 8
Genoa 7
Rio de Janeiro 7
Salvador 7
Tanta 7
Tashkent 6
Turin 6
Curitiba 5
Duque de Caxias 5
Guangzhou 5
Lauterbourg 5
Montreal 5
Ottawa 5
Quito 5
Cipolletti 4
Karachi 4
Mascalucia 4
North Bergen 4
São José dos Campos 4
Taipei 4
Berlin 3
Brussels 3
Chengdu 3
Fortaleza 3
Guayaquil 3
Joinville 3
Kampala 3
Macapá 3
Marília 3
Melbourne 3
Mumbai 3
New York 3
Newark 3
Porto Alegre 3
Riga 3
Sivas 3
Sorocaba 3
São José do Rio Preto 3
The Dalles 3
Warsaw 3
Aci Sant'Antonio 2
Agadir 2
Alcamo 2
Almenara 2
Amman 2
Aracaju 2
Arapongas 2
Araraquara 2
Baku 2
Bangkok 2
Bari 2
Bauru 2
Beijing 2
Belpasso 2
Belém 2
Bogotá 2
Buenos Aires 2
Campinas 2
Canoas 2
Caratinga 2
Contagem 2
Cotia 2
Enna 2
Graz 2
Guildford 2
Hadera 2
Ipatinga 2
Itabira 2
Itaperuna 2
Totale 18.249
Salva come PNG Salva come JPEG
Nome #
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.147
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 946
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 938
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 693
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 619
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 539
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 473
Predicting neocommissural orientation during TAVI workup 470
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 410
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 360
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 346
Le nuove frontiere della cardiologia interventistica strutturale 337
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 137
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 123
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 100
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 99
Transcatheter mitral valve implantation: CardiAQ 97
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 96
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 85
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 85
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 82
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 80
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 80
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 80
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 79
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 78
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 78
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 76
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 75
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 74
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 68
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 66
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 65
Managing complications after transcatheter aortic valve implantation 63
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 63
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 62
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 62
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 61
Early detection of transcatheter heart valve dysfunction 61
The Helio transcatheter aortic dock for patients with aortic regurgitation 59
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 59
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 59
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 58
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 58
Cerebral embolization during transcatheter aortic valve implantation 58
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 58
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 58
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 58
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 58
Transcatheter mitral valve repair: a brief review 57
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 57
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 57
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 57
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 57
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 56
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 56
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 56
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 56
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 56
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 56
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 55
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 55
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era: A “Die-Hard” Procedure 55
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 55
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 55
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 54
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 54
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 54
Bioprosthetic valves for transcatheter aortic valve replacement 54
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 54
Management of severe stenosis controversies and promises 54
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 54
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 54
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 53
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 53
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 53
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 53
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 53
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 52
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 52
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 52
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 52
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 52
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 52
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 51
Plug-Based Endovascular Closure of Large Bore Aortofemoral Graft Arteriotomy for Transcatheter Aortic Valve Replacement 51
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 51
Transcatheter aortic valve replacement in bicuspid aortic valve disease 51
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 51
Early discharge after transfemoral transcatheter aortic valve implantation 51
Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation 51
Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis 50
Feasibility and predictors of early discharge after percutaneous edge-to-edge mitral valve repair 50
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 50
Protesi Percutanee Aortiche: Le indicazioni si allargano 50
How to Avoid Coronary Occlusion During TAVR Valve-in-Valve Procedures 49
Sinus of Valsalva Sequestration Following Transcatheter-Based Management of ACURATE neo2 Valve Embolization 49
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 49
The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation 49
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 49
Totale 12.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202512.586 1.491 249 544 152 610 681 7.367 307 978 207 0 0
Totale 21.546